Lung function and respiratory symptoms in association with mortality: The HUNT study

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 11, Issue 1, 2014, Pages 59-80

  Leivseth, Linda ^a   Nilsen, Tom Ivar Lund ^a   Mai, Xiao Mei ^a   Johnsen, Roar ^a   Langhammer, Arnulf ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Cardiovascular; Cough; Dyspnoea; Epidemiology; Forced expiratory volume; Wheeze

Indexed keywords

BRONCHODILATING AGENT;

ADULT; AGED; ALL CAUSE MORTALITY; ARTICLE; CARDIOVASCULAR MORTALITY; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HAZARD RATIO; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RESPIRATORY AIRFLOW; SPIROMETRY; VERY ELDERLY; WALKING; WHEEZING;

ADULT; AGED; BODY MASS INDEX; BRONCHITIS, CHRONIC; CARDIOVASCULAR DISEASES; COHORT STUDIES; COUGH; DIABETES MELLITUS; DYSPNEA; EDUCATIONAL STATUS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYPERCHOLESTEROLEMIA; LONGITUDINAL STUDIES; LUNG; MALE; MIDDLE AGED; MORTALITY; MOTOR ACTIVITY; NORWAY; PROPORTIONAL HAZARDS MODELS; RESPIRATORY FUNCTION TESTS; RESPIRATORY SOUNDS; RISK FACTORS; SMOKING;

EID: 84893211983     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2013.781578     Document Type: Article

References (38)

1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of COPD 2011 [updated 11 January 2012 cited 2012 21 May ]. Available from: http://www.goldcopd.org.
2. Fromer L. Diagnosing and treating COPD: understanding the challenges and fi nding solutions. Inter J Gen Med 2011; 4:729-739.
3. Yawn BP, Wollan PC. Knowledge and attitudes of family physicians coming to COPD continuing medical education. Int J Chron Obstruct Pulmon Dis 2008; 3(2):311-317.
4. Gulsvik AK, Gulsvik A, Skovlund E, et al. Th e association between lung function and fatal stroke in a community followed for 4 decades. J Epidemiol Community Health 2012;66(11):1030-1036.
5. Mannino DM, Diaz-Guzman E, Buist S. Pre- and postbronchodilator lung function as predictors of mortality in the Lung Health Study. Respir Res 2011; 12:136.
6. Sin DD, Wu L, Man SF. Th e relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005; 127(6):1952-1959.
7. Stavem K, Aaser E, Sandvik L, et al. Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males. Eur Respir J 2005; 25(4):618-625.
8. Schunemann HJ, Dorn J, Grant BJ, et al. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buff alo Health Study. Chest 2000; 118(3):656-664.
9. Hole DJ, Watt GC, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: fi ndings from the Renfrew and Paisley prospective population study. BMJ 1996; 313(7059):711-715.
10. Lange P, Nyboe J, Appleyard M, et al. Spirometric fi ndings and mortality in never-smokers. J Clin Epidemiol 1990; 43(9):867-873.
11. Baughman P, Marott JL, Lange P, et al. Health outcomes associated with lung function decline and respiratory symptoms and disease in a community cohort. COPD 2011; 8(2):103-113.
12. Mannino DM, Doherty DE, Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classifi cation of lung disease and mortality: fi ndings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006; 100(1):115-122.
13. Ekberg-Aronsson M, Pehrsson K, Nilsson JA, et al. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005; 6:98.
14. Mannino DM, Buist AS, Petty TL, et al. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003; 58(5):388-393.
15. Knuiman MW, James AL, Divitini ML, et al. Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study. Ann Epidemiol 1999; 9(5):297-306.
16. Lange P, Nyboe J, Appleyard M, et al. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990; 45(8):579-585.
17. Vollmer WM, McCamant LE, Johnson LR, et al. Respiratory symptoms, lung function, and mortality in a screening center cohort. Am J Epidemiol 1989; 129(6):1157-1169.
18. Ebi-Kryston KL, Hawthorne VM, Rose G, et al. Breathlessness, chronic bronchitis and reduced pulmonary function as predictors of cardiovascular disease mortality among men in England, Scotland and the United States. Int J Epidemiol.1989; 18(1):84-88.
19. Ebi-Kryston KL. Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study. J Clin Epidemiol 1988; 41(3):251-260.
20. Frostad A, Soyseth V, Haldorsen T, et al. Respiratory symptoms and long-term cardiovascular mortality. Respir Med 2007; 101(11):2289-2296.
21. Frostad A, Soyseth V, Andersen A, et al. Respiratory symptoms as predictors of all-cause mortality in an urban community: a 30-year follow-up. J Intern Med 2006; 259(5):520-529.
22. Hewitt J, Smeeth L, Bulpitt CJ, et al. Respiratory symptoms in older people and their association with mortality. Thorax 2005; 60(4):331-334.
23. Carpenter L, Beral V, Strachan D, et al. Respiratory symptoms as predictors of 27 year mortality in a representative sample of British adults. BMJ 1989; 299(6695):357-361.
24. Figarska SM, Boezen HM, Vonk JM. Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/Vlaardingen study. Eur J Epidemiol 2012; 27(11):867-876.
25. Helseundersøkelsen i Nord-Trøndelag 2012 [updated May 11 2012; cited 2012 May 21]. Available from: http://www.ntnu. edu/hunt.
26. Krokstad S, Langhammer A, Hveem K, et al. Cohort Profi le: Th e HUNT Study, Norway. Int J Epidemiol [published online ahead of print 9 August 2012]. (doi:10.1093/ije/dys095).
27. Holmen J, Midthjell K, Krüger Ø, et al. Th e Nord-Trøndelag Health Study 1995-97 (HUNT 2): Objectives, contents, methods and participation. Norsk Epidemiolog 2003; 13(1):19-32.
28. Leivseth L, Nilsen TI, Mai XM, et al. Lung function and anxiety in association with dyspnoea: Th e HUNT study. Respir Med 2012; 106(8):1148-1157.
29. Langhammer A, Johnsen R, Gulsvik A, et al. Forced spirometry reference values for Norwegian adults: the Bronchial Obstruction in Nord-Trøndelag Study. Eur Respir J 2001; 18(5):770-779.
30. Standardization of Spirometry, 1994 Update. American Th oracic Society. Am J Respir Crit Care Med 1995; 152(3):1107-1136.
31. Brogger JC, Bakke PS, Gulsvik A. Comparison of respiratory symptoms questionnaires. Int J Tuberc Lung Dis 2000; 4(1):83-90.
32. Seaman SR, White IR. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res [published online ahead of print January 10, 2011]. (doi:10.1177/0962280210395740).
33. Becklake MR, Kauff mann F. Gender diff erences in airway behaviour over the human life span. Thorax 1999; 54(12):1119-1138.
34. Hernán MA, Robins JM. Causal Inference 2012 [updated 2012 Nov 25 cited 2012 Des 11]. Available from: http://www.hsph.harvard. edu/faculty/miguel-hernan/fi les/hernanrobins-v1.10.19.pdf.
35. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology, 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008.
36. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33(5):1165-1185.
37. Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Th oracic Society. Am J Respir Crit Care Med 1999; 159(1):321-340.
38. Langhammer A, Johnsen R, Holmen J, et al. Cigarette smoking gives more respiratory symptoms among women than among men. Th e Nord-Trøndelag Health Study (HUNT). J Epidemiol Commun Health 2000; 54(12):917-922.